Table 2.
Anticoagulation for portal vein thrombosis in patients with cirrhosis
| Author, year, (Ref) | Number of patients, study design | Age of thrombosis | Grade of PVT partial/occlusive (n) | Resolution of PVT partial/complete/any (%) |
|---|---|---|---|---|
| Francoz, 2005[21] | 19, prospective | n.d.* | 8/11 | 0/42/42 |
| Amitrano, 2010[30] | 28, prospective | n.d.* | 23/5 | 50/33/83 |
| Delgado, 2012[14] | 55, prospective | Acute 31 Chronic 24 median 9 days (0-298) | 41/14 | 15/40/55 |
| Senzolo, 2012[13] | 35, prospective | n.d.* | 24/11 | 27/36/63 |
| Werner, 2013[31] | 28, retrospective | n.d.* | n.d.* | 43/39/82 |
| Naeshiro, 2014[15] | 26, retrospective | 40 days (0-1800) | n.d.* | 62/15/77 |
| Qi, 2015[19] | 430, (16 studies) meta-analysis | n.d.* | n.d.* | 25.1/41.5/66.6 |
PVT: portal vein thrombosis.
*
n.d.: no sufficient data;